medium · Private Credit underwriting-credit-analysis
A borrower identifies that it will breach its leverage covenant next quarter. The sponsor proposes an 'Equity Cure' of $10M.
If the Credit Agreement defines the cure as 'Deemed EBITDA' for the quarter it is injected and the three subsequent quarters, how does this impact the leverage ratio (Debt / LTM EBITDA)?
- It increases the denominator by $10M for the next four rolling periods.
- It only provides a cure for the specific quarter in which the breach occurred.
- It reduces the numerator (Debt) by $10M immediately.
- It has no effect on the LTM calculation since it is a one-time injection.
Sign up free to see the explanation and track your rank →
More Private Credit underwriting-credit-analysis practice
- If the investor hedges the currency risk using forward contracts, what is the approximate
- A lender is determining the maximum debt capacity for an LBO… — What is the maximum suppor
- What is the Enterprise Value?
- If the sponsor uses $360 million in total debt, what is the entry Net Debt / EBITDA levera
- A credit agreement includes a 75% 'Excess Cash Flow Sweep'.… — How much of this cash must
- If the fund provides a $200M senior loan, how does the inclusion of add-backs affect the r
- If the pool suffers a 2% annual default rate with a 65% recovery rate, what is the adjuste
- If the cumulative probability of default over a 5-year investment horizon is 8%, what is t